
Sign up to save your podcasts
Or


Annemieke Aartsma-Rus and Elizabeth Vroom discuss with Patricia Lobo the developments in Duchenne muscular dystrophy therapy and how this can serve as a paradigm for development of treatment for rare diseases.
By The Lancet NeurologyAnnemieke Aartsma-Rus and Elizabeth Vroom discuss with Patricia Lobo the developments in Duchenne muscular dystrophy therapy and how this can serve as a paradigm for development of treatment for rare diseases.

43,580 Listeners

293 Listeners

517 Listeners

50 Listeners

112,238 Listeners

93 Listeners

513 Listeners

190 Listeners

61 Listeners

83 Listeners

0 Listeners